跳至主要内容
临床试验/KCT0006043
KCT0006043招募中未知

A comparative study of a deeply-inserted acupotomy applied to Hyeopcheok points and usual Korean Medicine treatments for lumbosacral radiculopathy : safety, effectiveness, cost-effectiveness (A randomized controlled, two-arm, parallel study, pilot study, assessor-blind): a study protocol

Catholic Kwandong University0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 85?(Year)(—)
性别
All

入选标准

  • 1) Adult men and women aged 19-85
  • 2) Those who have been diagnosed with spondylosis with lumbosacral disc disorder (injury), spinal stenosis, lumbosacral radiculopathy. through radiological examination (MRI or CT) within 6 months prior to participation in the clinical trial (In the case of a patient suspected of lumbosacral radiculopathy but no imaging record at the time of the screening test, MRI or CT scans are performed to check whether it meets the diagnostic criteria)
  • 3) Patients who have symptoms related to lumbosacral radiculopathy, such as radiological pain, muscle weakness, and paresthesia of the lower extremities, or who have been diagnosed with radiculopathy of the lumbosacral spine through a physical examination.
  • 4) Patients with NRS 4 or higher with pain/discomfort due to lumbosacral radiculopathy
  • 5) Patients who read the symptom questionnaire and can understand and answer its meaning
  • 6) Patients who voluntarily consent to the approved written consent of the Institutional Review Board while agreeing to the clinical trail plan and follow-up

排除标准

  • 1) Patients who have a history of spinal surgery such as lumbar spine intrametallic fixation and spinal fusion, or who have undergone past spinal surgery but continue to have related pain afterwards
  • 2) Patients with cauda equina syndrome or motor paralysis and neurological symptoms, which are expected to be difficult to recover with conservative therapy, and who are judged to require surgical treatment
  • 3) Patients undergoing drug treatment such as strong opioid for the purpose of pain control
  • 4) Patients who received Korean medicine treatment within 2 weeks before the start of the clinical study baseline
  • (If, at the discretion of the clinical trial practitioner, treatment at another institution within the relevant period is determined to be a new neuropathic symptom different from the existing pain, it is possible to participate in this clinical trial)
  • 5) Patients with acupuncture hypersensitivity, metal allergy, severe atopy, keloid skin, and other skin sensitivity
  • 6) Patients with hemophilia
  • 7) Patients who are taking drugs that can cause hemostasis, such as anticoagulants, antiplatelet drugs, aspirin, etc., and that it is not possible to stop the drug during the clinical trial period at the judgment of the clinical trial practitioner.
  • 8) Those who participated in other clinical studies within 30 days prior to clinical study screening and received investigational drugs including placebo
  • 9) Patients with psychotic disorder, alcoholics, and drug addicts
  • 10) Pregnant and lactating women, women of childbearing potential who are not willing to use contraception during the clinical trial
  • 11) Those who is judged to be inappropriate for participation in clinical trials as judged by the clinical trial practitioner.

研究者

相似试验